Evonik's CDMO solutions for APIs and HPAPIs: It specializes where the client needs it most!
Please Wait
Applying Filters...
01 6Evonik
02 1SPI Pharma
03 2Aeon Procare
04 3Alcedo Pharmachem
05 17BASF
06 2Gangwal Chemicals
07 6Ideal Cures Pvt Ltd
08 14Kerry
09 1Kima Chemical
10 1Lonza Capsugel
11 1Sigachi Industries
12 2The Dow Chemical Company
Evonik's CDMO solutions for APIs and HPAPIs: It specializes where the client needs it most!
Application : Controlled & Modified Release, Solubilizers
Excipient Details : EUDRAGIT® L 100 (powder), a delayed release polymer is used to increase solubility of poorly soluble products such as tablets, capsules, ODTs, etc.
Evonik's CDMO solutions for APIs and HPAPIs: It specializes where the client needs it most!
Ingredient(s) : METHACRYLIC ACID COPOLYMER TYPE A
Category : Controlled & Modified Release, Solubilizers
Brand : EUDRAGIT® L 100
Pharmacopoeia Ref : NA
Technical Specs : NA
Grade : Oral
SPI Pharma has been solving formulation challenges using superior functional materials.
Dosage Form : Tablet
Grade : Oral
Application : Coating Systems & Additives, Controlled & Modified Release
Excipient Details : ACTILLETS are microcrystalline cellulose spheres developed using advanced drug delivery technology to enable effective loading & coating of particles.
Pharmacopoeia Ref : NA
Technical Specs :
Ingredient(s) : Microcrystalline Cellulose
Dosage Form : Tablet
Grade : Oral
SPI Pharma has been solving formulation challenges using superior functional materials.
Ingredient(s) : Microcrystalline Cellulose
Dosage Form : Tablet
Category : Coating Systems & Additives, Controlled & Modified Release
Brand : ACTILLETS™
Pharmacopoeia Ref : NA
Technical Specs : Not Available
Grade : Oral
Evonik's CDMO solutions for APIs and HPAPIs: It specializes where the client needs it most!
Dosage Form : Capsule, Granule / Pellet, Tablet
Grade : Oral
Brand Name : EUDRAGIT® L 100-55
Application : Coating Systems & Additives, Controlled & Modified Release, Solubilizers
Excipient Details : EUDRAGIT® L 100-55 (powder) is used in delayed release coatings to enhance solubility of poorly soluble drugs such as tablets, capsules & granules.
Pharmacopoeia Ref : NA
Technical Specs : NA
Ingredient(s) : Methacrylic Acid - Ethyl Acrylate Copolymer
Dosage Form : Capsule, Granule / Pellet, Tablet
Grade : Oral
Evonik's CDMO solutions for APIs and HPAPIs: It specializes where the client needs it most!
Ingredient(s) : Methacrylic Acid - Ethyl Acrylate Copolymer
Dosage Form : Capsule, Granule / Pellet, Tablet
Category : Coating Systems & Additives, Controlled & Modified Release, Solubilizers
Brand : EUDRAGIT® L 100-55
Pharmacopoeia Ref : NA
Technical Specs : NA
Grade : Oral
Evonik's CDMO solutions for APIs and HPAPIs: It specializes where the client needs it most!
Dosage Form : Tablet
Grade : Oral
Brand Name : EUDRAGIT® RS 12,5
Application : Controlled & Modified Release
Excipient Details : EUDRAGIT® RS 12,5 (Organic solution) is a sustained release polymer for customized release profiles used in combination with EUDRAGIT® RL.
Pharmacopoeia Ref : NA
Technical Specs : NA
Ingredient(s) : Ethyl Acrylate Methyl Methacrylate Copolymer, Methacrylic Acid Excipient
Dosage Form : Tablet
Grade : Oral
Evonik's CDMO solutions for APIs and HPAPIs: It specializes where the client needs it most!
Ingredient(s) : Ethyl Acrylate Methyl Methacrylate Copolymer, Methacrylic Acid Excipient
Dosage Form : Tablet
Category : Controlled & Modified Release
Brand : EUDRAGIT® RS 12,5
Pharmacopoeia Ref : NA
Technical Specs : NA
Grade : Oral
